Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Moderna closes $450mm third round

Executive Summary

Messenger RNA firm Moderna Therapeutics LLC closed the largest biotech venture funding round to date, bringing in $450mm through its third financing from a group of 43 investors that included new buyers Viking Global Investors, Invus, RA Capital, and Wellington Management, along with returning backers AstraZeneca, Alexion Pharmaceuticals, and 37 others.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Antisense, Oligonucleotides
    • Large Molecule
    • Drug Discovery Tools
      • Genomics-Proteomics
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies